HMR plans to cut outsourcing of clinical trials: new facility could allow 70% to be handled internally.
Executive Summary
HOECHST MARION ROUSSEL PLANS INCREASE OF INTERNAL TRIAL MANAGEMENT TO 50%-70% in a year and a half, HMR Assistant Director for Clinical Research, Planning & Coordination David Gillogly said at an Institute for International Research conference on "Cost Management for Clinical Trials" in Washington June 19. Following its move into a new facility 15 months ago, Hoechst plans to increase trial management staff to 150-160. Hoechst currently has a trial management staff of 110 and has outsourced 100% of its trials for the past two years, Gillogly said.